84487-08-1

Basic information

• Product Name: 2-AMINO-4-METHOXY-3-NITROPYRIDINE
• Synonyms: 2-AMINO-4-METHOXY-3-NITROPYRIDINE;4-Methoxy-3-nitro-pyridin-2-ylamine;4-Methoxy-3-nitropyridin-2-amine
• CAS NO: 84487-08-1
• Molecular Formula: C₆H₇N₃O₃
• Molecular Weight: 169.13808
• Product Categories: Nucleotides and Nucleosides;Bases & Related Reagents;Nucleotides;Pyridines
• Mol File: 84487-08-1.mol
• Article Data: 9

Chemical Properties

• Melting Point: 183-186°C
• Boiling Point: 356.8 °C at 760 mmHg
• Flash Point: 169.6 °C
• Appearance: Yellow Crystalline Solid
• Density: 1.4 g/cm³
• Vapor Pressure: 2.85E-05mmHg at 25°C
• Refractive Index: 1.608
• Storage Temp.: 2-8°C
• Solubility: Chloroform, Ethanol, Ethyl Acetate, Methanol
• CAS DataBase Reference: 2-AMINO-4-METHOXY-3-NITROPYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AMINO-4-METHOXY-3-NITROPYRIDINE(84487-08-1)
• EPA Substance Registry System: 2-AMINO-4-METHOXY-3-NITROPYRIDINE(84487-08-1)

Safety Data

• Hazardous Substances Data: 84487-08-1(Hazardous Substances Data)

Usage

Chemical Properties

Yellow Crystalline Solid

InChI:InChI=1/C6H7N3O3/c1-12-4-2-3-8-6(7)5(4)9(10)11/h2-3H,1H3,(H2,7,8)

Upstream product

• 67-56-1 methanol 
• 6980-08-1 4-chloro-3-nitro-2-pyridinamine 
• 124-41-4 sodium methylate 
• 84487-10-5 2-amino-4-bromo-3-nitropyridine 
• 84249-02-5 2-nitroamino-4-bromopyridine 
• 1072-97-5 5-bromo-2-pyridylamine 
• 10201-73-7 2-amino-4-methoxypyridine 
• 5470-22-4 4-chloropicolinic acid 
• 19798-80-2 2-Amino-4-chloropyridine 
• 84249-01-4 C₆H₇N₃O₃ 
• 130721-78-7 tert-butyl (4-chloropyridin-2-yl) carbamate 

Downstream Products

• 1426833-17-1 1-(2-chloro-phenyl)-6-methoxy-4-methyl-2,3,5,9,9b-pentaazacyclopenta[a]naphthalene 
• 1426824-69-2 N-[1-(2-chloro-phenyl)-methylidene]-N'-(8-methoxy-2-methyl-pyrido[2,3-b]pyrazin-3-yl)-hydrazine 
• 1426833-18-2 1-(2-chloro-6-methyl-phenyl)-6-methoxy-4-methyl-2,3,5,9,9b-pentaazacyclopenta[a]naphthalene 
• 1426833-19-3 1-(2,6-bismethyl-phenyl)-6-methoxy-4-methyl-2,3,5,9,9b-pentaazacyclopenta[a]naphthalene 
• 127356-03-0 2-(4-Methanesulfinyl-2-methoxy-phenyl)-7-methoxy-1H-imidazo[4,5-b]pyridine 
• 127356-20-1 7-Methoxy-2-(2-methoxy-4-methylsulfanyl-phenyl)-1H-imidazo[4,5-b]pyridine 
• 127356-16-5 4-methoxy-pyridine-2,3-diamine 

Relevant articles and documents

Polycyclic compound for inhibiting RNA helicase DHX33

The invention relates to a polycyclic compound for inhibiting RNA helicase DHX33. In particular, the invention relates to a compound shown as a formula I or a pharmaceutically acceptable form thereof, a pharmaceutical composition containing the compound, a preparation method of the compound, and medical application of the compound to prevention and/or treatment of DHX33 related diseases.

A model D - amino acid oxidase inhibitor and its preparation and application

The invention provides a novel D- amino acid oxidase inhibitor and a preparation and application thereof. In particular, the invention discloses derivatives of quinoxaline-2,3-diketone, which has a novel structure shown in formula A, as well as a preparation method thereof and an application as an inhibitor of D-amino acid oxidase (DAAO). The compound provided by the invention shows excellent effects of analgesia and blocking morphine analgesia tolerance, and has application value for analgesia, treating opiate drug tolerance, and anti-schizophrenia.

2-(HETERO)ARYL-BENZIMIDAZOLE AND IMIDAZOPYRIDINE DERIVATIVES AS INHIBITORS OF ASPARAGIME EMETHYL TRANSFERASE

Substituted benzimidazole and 3H-imidazo[4,5-b]pyridines or formula I: where X and Y respectively are selected from: (i) N and N; and (ii) N and CR4; A2 is selected from:, a C5 heteroarylene group, containing 2 or 3 ring heteroatoms, where the bonds to L1 and the core are β to one another; L1 is selected from: (i)A1-O-CH2-A2; (ii)A1-CH2-O-A2; (iii)A1-C(=O)-NH-A2; (iv)A1-CH(OH)-A2; (v)A1-CH2-NH-C(=O)-A2; (vi) A1-S-CH2-A2; (vii)A1- CH2-S-A2; (viii)A1-CH2-A2; and (ix)A1-CH(CH3)-O-A2; A1 is phenyl, optionally substituted by F or CF3; their use as pharmaceuticals, and in particular, in treating cancer and hemoglobinopathies.